🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Research The University of Edinburgh using AI to develop faster and cheaper enzyme replacement therapies for rare diseases that can impact children is awarded £74,600 Scottish Enterprise spin-out funding to aid commercialisation #ZYTHERA #LifeSciences #AI Edinburgh Innovations - Find us on Bluesky 🦋 ow.ly/yZER50OPCsI

Looking forward to help patients with #Lysosomal #Storage #Diseases #LSD doing what we do best: #AI and #engbio. Thanks Scottish Enterprise for the support.

Hi everyone, please come along to what will be a very interesting talk by Sudarshan Pinglay! This will be a joint session with EUSynBioS and Centre for Engineering Biology/Biological Sciences | University of Edinburgh, taking place in the Waddington Seminar room. All welcome to join in-person or via the Zoom link 🧬

Very excited to lead one of the #AI for #health #research projects with @RosserLab and Dr Eve Miller-Hodges. We will develop new methods to design and make less #immunogenic #ERTs for #Fabry disease. bit.ly/idert Biological Sciences | University of Edinburgh Centre for Engineering Biology MPS Society UK, here for those with rare diseases UK Research and Innovation

We had a great meeting yesterday with Department for Science, Innovation and Technology #EngBio team and IBioIC presenting our #AI and #EngBio platform to make new #ERTs for lysosomal storage diseases #LSD. Excellent feedback and great new connections. Biological Sciences | University of Edinburgh Centre for Engineering Biology

It was great to meet #patients and #doctors of Edinburgh Kidney. Here collaborator, Dr Eve Miller-Hodges, introducing our #Fabry #ERT deimmunization project and the power #AI in drug discovery. Exciting times ahead! Biological Sciences | University of Edinburgh Centre for Engineering Biology UK Research and Innovation Rare Disease UK

Researchers at the The University of Edinburgh, in partnership with the synthetic DNA company Neochromosome and supported by IBioIC, have unveiled a tool utilising AI to assist with the process of enzyme selection for therapeutic treatments. digit.fyi/scots-research…

A new collaboration aims to improve the creation of safer and more effective therapeutics, including enzyme replacement therapy, for a diverse range of genetic diseases. synbiobeta.com/read/ai-powere…

We’re excited our team is part of this Biotechnology and Biological Sciences Research Mission Hub at the forefront of next generation therapeutics development!